Immuron Limited (IMRN) Financials

IMRN Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 13.5 million 1.6 million
2023-06-30 14.6 million 1.6 million
2023-03-31 14.8 million 1.6 million
2022-12-31 15.7 million 1.3 million

IMRN Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 ? ?
2023-06-30 -1.0 million 75284
2023-03-31 -538190 76157
2022-12-31 -646787 ?

IMRN Net Income

No data available :(

IMRN Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 11.2 million - -
2023-06-30 12.6 million - 125449
2023-03-31 11.5 million - -
2022-12-31 13.0 million - 131326

IMRN Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 155.2 million
2023-06-30 151.1 million
2023-03-31 152.9 million
2022-12-31 155.2 million

IMRN Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 - 1.8 million - -
2023-06-30 445 710207 783186 154788
2023-03-31 225 359221 792268 156583
2022-12-31 4813 1.0 million 633455 156940

IMRN Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 1.6 million 528165
2023-06-30 810086 225454
2023-03-31 409740 30569
2022-12-31 397566 106077

IMRN

Price: $2.52

52 week price:
1.48
5.96

Earnings Per Share: -0.44 USD

P/E Ratio: -3.98

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 1327

Ebitda: -6.8 million

Market Capitalization: 16.2 million

Links: